|Bid||0.00 x 2900|
|Ask||10.38 x 2200|
|Day's Range||6.53 - 6.65|
|52 Week Range||5.35 - 12.04|
|PE Ratio (TTM)||N/A|
|Earnings Date||Jun 9, 2017 - Jun 12, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||10.00|
Enzo Biochem, Inc. and its subsidiary Enzo Life Sciences, Inc. today announced that the Patent Trial and Appeal Board has denied a petition filed by Hologic, Inc. for inter partes review, a procedure for challenging the validity of patent claims, against U.S.
Enzo Biochem (NYSE: ENZ ) unveils its next round of earnings Tuesday. Get prepared with Benzinga's ultimate preview for Enzo Biochem's Q2 earnings. Earnings and Revenue Enzo Biochem EPS is expected to ...
NEW YORK, NY / ACCESSWIRE / March 13, 2018 / Enzo Biochem, Inc. (NYSE: ENZ ) will be discussing their earnings results in their Q2 Earnings Call to be held on March 13, 2018, at 8:30 AM Eastern Time. To ...
On a per-share basis, the New York-based company said it had a loss of 2 cents. Losses, adjusted for pretax gains, were 4 cents per share. The life sciences and biotechnology company posted revenue of ...
Enzo Biochem, Inc. will hold a conference call to discuss fiscal 2018 second quarter results Tuesday, March 13, 2018, at 8:30 AM E.T.
NEW YORK, Feb. 26, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Enzo ...
Enzo Biochem, Inc. , an integrated diagnostics company, announced today validation of a cervical cancer biomarker detection test that provides a highly robust and cost-efficient solution for anatomical pathology.
LONDON, UK / ACCESSWIRE / January 09, 2018 / Active-Investors.com has just released a free earnings report on Enzo Biochem, Inc. (NYSE: ENZ ). If you want access to this report all you need to do is sign ...
Stock Monitor: Enzo Biochem Post Earnings Reporting LONDON, UK / ACCESSWIRE / December 13, 2017 / Active-Investors issued a free report on Cancer Genetics, Inc. (NASDAQ: CGIX ), which is readily accessible ...
NEW YORK, NY / ACCESSWIRE / December 8, 2017 / Enzo Biochem, Inc. (NYSE: ENZ ) will be discussing their earnings results in their Q1 Earnings Call to be held on December 8, 2017 at 8:30 AM Eastern Time. ...
The New York-based company said it had a loss of 1 cent per share. The life sciences and biotechnology company posted revenue of $27.7 million in the period. Enzo Biochem shares have climbed 37 percent ...
Enzo Biochem Inc. today reported improved operating results for the first fiscal quarter ended October 31, 2017, including year over year double digit revenue growth at Enzo Clinical Labs.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Enzo Biochem, Inc. Here are 5 ETFs with the largest exposure to ENZ-US. Comparing the performance and risk of Enzo Biochem, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
Enzo Biochem, Inc. will hold a conference call to discuss fiscal 2018 first quarter results Friday, December 8, 2017, at 8:30 AM E.T.